Search
for

    Sort by

    Research 271–300 of 1000+

    1. Increased Efficacy of Daytime Low-dose Oral Minoxidil Dosing for Androgenetic Alopecia: A Retrospective Study British Journal of Dermatology · 2026
    2. The efficacy and safety of oral minoxidil greater than 5.1-10 mg daily in hair loss disorders Mendeley Data · 2026
    3. The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders Mendeley Data · 2026
    4. The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review Mendeley Data · 2026
    5. The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders: A systematic review Mendeley Data · 2026
    6. 74924 Oral Minoxidil for Pediatric and Adolescent Hair Loss: A Cross-Sectional Survey of Satisfaction and Perceived Benefit Journal of the American Academy of Dermatology · 2026
    7. 76626 Adjunctive Combined Regenerative Technique (CRT) vs Oral Minoxidil Alone for Androgenetic Alopecia: A Six-Month Retrospective Study Journal of the American Academy of Dermatology · 2026
    8. Low Dose Oral Minoxidil in Androgenetic Alopecia Journal of College of Physicians And Surgeons Pakistan · 2026
    9. 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study Journal of the American Academy of Dermatology · 2026
    10. ORAL MINOXIDIL EFFICACY AND SAFETY IN MALE ANDROGENETIC ALOPECIA - A LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2026
    11. Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial Preprints.org · 2026
    12. Oral tofacitinib for recalcitrant lichen planus pigmentosus: A hospital-based retrospective study Journal of General-Procedural Dermatology & Venereology Indonesia · 2026
    13. P166 Real-world efficacy and tolerability of oral dutasteride combined with oral minoxidil for male androgenetic alopecia: a retrospective cohort study British Journal of Dermatology · 2026
    14. Frontal Fibrosing Alopecia Successfully Treated with Intralesional Betamethasone and Oral Hydroxychloroquine: A Case Report Scholars Journal of Medical Case Reports · 2026
    15. No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study Journal of the American Academy of Dermatology · 2026
    16. Evaluating the Effectiveness of Commercial Oral Supplements for Hair Growth: A Systematic Review and Meta‐Analysis Journal of Cosmetic Dermatology · 2026
    17. Comparative Study of effectiveness of low dose Oral Minoxidil vs Topical Minoxidil (5%) in Male Androgenetic Alopecia. Journal of Pakistan Association of Dermatologists · 2026
    18. O IMPACTO DO USO PERIOPERATÓRIO DA DUTASTERIDA (ORAL E MESOTERAPIA) NOS RESULTADOS ESTÉTICOS DO TRANSPLANTE CAPILAR: UMA REVISÃO DE LITERATURA Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    19. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    20. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    21. Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience Immunological Medicine · 2026
    22. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    23. Placebo effect of topical and oral treatments for androgenetic alopecia A systematic review and meta-analysis Mendeley Data · 2026
    24. Rethinking Oral Minoxidil: Distinguishing the Hair-Growth Window from the Cardiovascular Threshold Journal of the American Academy of Dermatology · 2026
    25. Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025) Life · 2026
    26. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    27. Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management Scientific Reports · 2026
    28. Oral Tofacitinib for Refractory Lichen Planus Pigmentosus Coexisting with Frontal Fibrosing Alopecia Indian Dermatology Online Journal · 2026
    29. Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study Frontiers in Medicine · 2026
    30. Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations Frontiers in Pharmacology · 2026